Use of antibody-drug conjugates

TW202639177APending Publication Date: 2026-10-01DAIICHI SANKYO CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115119467
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-05-15
Filing Date
2018-05-11
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001079696_001
    Figure TWG2TA001079696_001
  • Figure TWG2TA001079696_002
    Figure TWG2TA001079696_002
  • Figure TWG2TA001079696_003
    Figure TWG2TA001079696_003
Patent Text Reader

Abstract

The subject of this invention is to provide an antibody with intrinsic activity that binds to CDH6, an antibody-drug conjugate of the antibody and a drug with antitumor activity, a pharmaceutical product using the antibody-drug conjugate that has a therapeutic effect on tumors, and a treatment method for tumors using the antibody, the antibody-drug conjugate, or the pharmaceutical product. According to this invention, an anti-CDH6 antibody with intrinsic activity, an antibody-drug conjugate of the antibody and a drug with antitumor activity, a pharmaceutical product using these, and a treatment method for tumors can be provided.
Need to check novelty before this filing date? Find Prior Art